🔗 Permalink

Assignee profile:

MD BIOALPHA CO., LTD.

City:

Daejeon

Country:

South Korea

Published Applications:

Last publication date:

2014-04-17

Patent Grants:

Last grant date:

2015-06-30

Top Inventors for applications by MD BIOALPHA CO., LTD.

These are the the leading inventors for applications assigned to MD BIOALPHA CO., LTD.:

Taehwan Kwak 4 Gyeonggi-do, South Korea
Myunggyu Park 3 Gyeonggi-do, South Korea
Taehwan KWAK 3 Yongin-si, South Korea
In Geun JO 3 Cheonan-si, South Korea

Sang-Ku YOO 3 Gwacheon-si, South Korea
In Geun Jo 2 Chungcheongnam-do, South Korea
Myung-Gyu Park 2 Gyeonggi-do, South Korea
Sang Ku Yoo 2 Gyeonggi-do, South Korea

Myunggyu PARK 2 Yongin-si, South Korea
Myung-Gyu Park 2 Yongin-si, South Korea
Min-Kyung KUON 1 Suwon-si, South Korea
Min-Kyung Kuon 1 Gyeonggi-do, South Korea

Recent patent applications by MD BIOALPHA CO., LTD.

MD BIOALPHA CO., LTD. based in Daejeon, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-04-17

US20140106387A1

Chemistry; metallurgy

METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE

#2 | 2013-09-19 ✅ Patent 9,066,922 granted on 2015-06-30

US20130245111A1

Human necessities

Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases

#3 | 2010-10-28

US20100272791A1

Human necessities

COMPOSITION HAVING EFFECT ON TREATMENT AND PREVENTION OF DRY EYE SYNDROME

#4 | 2010-02-04 ✅ Patent 8,029,832 granted on 2011-10-04

US20100029760A1

Human necessities

Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity

#5 | 2009-11-26 ✅ Patent 8,466,141 granted on 2013-06-18

US20090292011A1

Human necessities

Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases

#6 | 2009-08-27

US20090215145A1

Chemistry; metallurgy

METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE

#7 | 2008-12-18

US20080311186A1

Human necessities

Composition Having Effect on Treatment and Prevention of Dry Eye Syndrome

#8 | 2008-06-19

US20080146655A1

Human necessities

Pharmaceutical Composition for the Treatment or Prevention of Diseases Involving Obesity, Diabetes, Metabolic Syndrome, Neuro-Degenerative Diseases and Mitochondria Dyfunction Diseases

#9 | 2007-10-25

US20070248698A1

Human necessities

Obesity and Metabolic Syndrome Treatment with Tanshinone Derivatives Which Increase Metabolic Activity

Also check out MD BIOALPHA CO., LTD.'s (Daejeon, South Korea) applicant profile with 1 patent applications submitted.

AssigneeID:

39633 ⎘